Table 1 Patient characteristics
Characteristics | Total | LZAP low | LZAP high | P-value |
|---|---|---|---|---|
Number of cases | 178 | 81 (45.5%) | 97(55.5%) | |
Gender | 0.88 | |||
Male | 86 (48.3%) | 38 (46.9%) | 48 (49.5%) | |
Female | 91 (51.1%) | 42 (51.9%) | 49 (50.5%) | |
NA | 1 (0.56%) | 0 | 1 (1.2%) | |
Age at Dx | 0.34 | |||
Median | 63 | 66 | 64 | |
Range | 35–89 | 42–89 | 35–83 | |
Mean | 62.4 | 65.8 | 64.3 | |
Staging | ||||
T | ||||
T1–T2 | 53 (29.8%) | 26 (32.1%) | 27 (27.8%) | 1.00 |
T3–T4 | 19 (10.7%) | 10 (12.3%) | 9 (9.3%) | |
NA | 106 (59.6%) | 45 (55.6%) | 61 (62.9%) | |
N | ||||
N0 | 34 (19.1%) | 18 (22.2%) | 16 (16.5%) | 0.25 |
N1–3 | 42 (23.6%) | 16 (19.8%) | 26 (26.8%) | |
NA | 102 (57.3%) | 47 (58.0%) | 55 (56.7%) | |
Stage | ||||
I–II | 124 (69.7%) | 62 (76.5%) | 62 (63.9%) | 0.10 |
III–IV | 53 (29.8%) | 19 (23.5%) | 34 (35.1%) | |
NA | 1 (0.56%) | 0 | 1 (1.2%) | |
